Cetera Investment Advisers’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$350K Sell
33,622
-707
-2% -$7.89K ﹤0.01% 4020
2026
Q1
$409K Buy
34,329
+3,212
+10% +$32.9K ﹤0.01% 3700
2025
Q4
$310K Buy
31,117
+9,497
+44% +$90.7K ﹤0.01% 3881
2025
Q3
$193K Buy
21,620
+6,076
+39% +$56.3K ﹤0.01% 4162
2025
Q2
$147K Sell
15,544
-3,643
-19% -$32.1K ﹤0.01% 3807
2025
Q1
$208K Buy
+19,187
New +$193K ﹤0.01% 3574

Other funds holding AHCO

Cetera Investment Advisers's AHCO Position: Q2 2026 in Review

Cetera Investment Advisers reduced its AdaptHealth (AHCO) stake by 2.1% in Q2 2026, selling an estimated $7.89K and leaving 33,622 shares worth $350K. The position accounts for ﹤0.01% of the portfolio, ranked #4020.

Cetera Investment Advisers first reported a position in AHCO in Q1 2025 and has held it in 6 quarters since. The position peaked at $409K in Q1 2026. 239 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Cetera Investment Advisers held 33,622 shares of AdaptHealth worth $350K as of Q2 2026.
  • Cetera Investment Advisers sold 707 AdaptHealth shares in Q2 2026, an estimated $7.89K.
  • AdaptHealth made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4020 holding.
  • Cetera Investment Advisers first reported a position in AdaptHealth in Q1 2025 and has held it in 6 quarters since.
  • Cetera Investment Advisers's AdaptHealth position peaked at $409K in Q1 2026.
  • 239 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.